TRAW
Traws Pharma·NASDAQ
--
--(--)
--
--(--)
5.43 / 10
Netural
TRAW's fundamentals score 5.4/10—fair but not compelling. Strengths include an inventory turnover ratio of 47.88 (Group 2) and an interest-coverage ratio of 15.5 (Group 1), both supporting financial health. However, the negative PB-ROE (-0.26) and low asset-to-market (-0.51) place the stock in weaker valuation groups, tempering the appeal. Revenue growth is explosive at 1541% YoY, yet this is accompanied by a neutral Total operating revenue trend, indicating possible sustainability concerns. Overall, the balance of factors earns a neutral fundamental rating.
Analysis Checks(6/10)
Revenue-MV
Value-0.26
Score3/3
Weight31.52%
1M Return11.03%
Value-0.26
Score3/3
Weight31.52%
1M Return11.03%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.62%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.62%
1M Return-1.23%
PB-ROE
Value-0.26
Score1/3
Weight25.59%
1M Return8.79%
Value-0.26
Score1/3
Weight25.59%
1M Return8.79%
Operating revenue (YoY growth rate %)
Value1541.18
Score0/3
Weight-10.20%
1M Return-5.31%
Value1541.18
Score0/3
Weight-10.20%
1M Return-5.31%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-2.16%
1M Return-0.98%
Value100.00
Score2/3
Weight-2.16%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value1541.18
Score0/3
Weight-12.26%
1M Return-6.54%
Value1541.18
Score0/3
Weight-12.26%
1M Return-6.54%
Profit-MV
Value3.97
Score3/3
Weight31.47%
1M Return10.40%
Value3.97
Score3/3
Weight31.47%
1M Return10.40%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.73%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.73%
1M Return-1.25%
Asset-MV
Value-0.51
Score0/3
Weight17.09%
1M Return6.58%
Value-0.51
Score0/3
Weight17.09%
1M Return6.58%
Cash-MV
Value-0.07
Score2/3
Weight24.29%
1M Return8.80%
Value-0.07
Score2/3
Weight24.29%
1M Return8.80%
Revenue-MV
Value-0.26
Score3/3
Weight31.52%
1M Return11.03%
Value-0.26
Score3/3
Weight31.52%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value1541.18
Score0/3
Weight-12.26%
1M Return-6.54%
Value1541.18
Score0/3
Weight-12.26%
1M Return-6.54%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.62%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.62%
1M Return-1.23%
Profit-MV
Value3.97
Score3/3
Weight31.47%
1M Return10.40%
Value3.97
Score3/3
Weight31.47%
1M Return10.40%
PB-ROE
Value-0.26
Score1/3
Weight25.59%
1M Return8.79%
Value-0.26
Score1/3
Weight25.59%
1M Return8.79%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.73%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.73%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value1541.18
Score0/3
Weight-10.20%
1M Return-5.31%
Value1541.18
Score0/3
Weight-10.20%
1M Return-5.31%
Asset-MV
Value-0.51
Score0/3
Weight17.09%
1M Return6.58%
Value-0.51
Score0/3
Weight17.09%
1M Return6.58%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-2.16%
1M Return-0.98%
Value100.00
Score2/3
Weight-2.16%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight24.29%
1M Return8.80%
Value-0.07
Score2/3
Weight24.29%
1M Return8.80%
Is TRAW undervalued or overvalued?
- TRAW scores 5.43/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -467.64% net margin, -3.07 P/E ratio, 3.45 P/B ratio, and 95.14% earnings growth, these metrics solidify its Netural investment rating.
